Sign in

CIK 0001396814

  • Large accelerated filer

Pacira BioSciences, Inc.

Sign in to watch
Ticker
PCRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
510619477
Phone
+1 650-242-8052
Business address
2000 SIERRA POINT PARKWAY, SUITE 900, BRISBANE, CA, 94005
Former names
Pacira Pharmaceuticals, Inc., PACIRA INC, Blue Acquisition Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$217,920
in 1 filing, $218K under 10b5-1 plans

Net −$217,920. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. RIKER LAUREN −$218K Senior Vice President, Finance sold 9% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-11-17 Froimson Mark Director Other disposition −20,136 $36.50 $735K 6,405
2026-11-17 Froimson Mark Director Returned to the company −6,405 $36.50 $234K 0
2026-11-17 Froimson Mark Director Returned to the company · Stock Option (Right to Buy) −4,693 0
2026-11-17 Froimson Mark Director Returned to the company · Stock Option (Right to Buy) −8,437 0
2026-11-17 Froimson Mark Director Returned to the company · Stock Option (Right to Buy) −8,027 0
2026-11-17 Froimson Mark Director Returned to the company · Stock Option (Right to Buy) −7,626 0
2026-11-17 Froimson Mark Director Returned to the company · Stock Option (Right to Buy) −8,225 0
2026-11-17 Froimson Mark Director Returned to the company · Stock Option (Right to Buy) −12,925 0
2026-11-17 Froimson Mark Director Returned to the company · Stock Option (Right to Buy) −11,279 0
2026-11-17 Froimson Mark Director Returned to the company · Stock Option (Right to Buy) −10,891 0
2026-11-17 Froimson Mark Director Returned to the company · Stock Option (Right to Buy) −8,144 0
2026-06-10 Froimson Mark Director Grant or award +6,405 26,541
2026-06-10 Froimson Mark Director Grant or award · Stock Option (Right to Buy) +10,891 10,891
2026-03-17 Froimson Mark Director Sale −500 $21.81 $11K 20,136
2025-06-11 Froimson Mark Director Grant or award +6,163 20,636
2025-06-11 Froimson Mark Director Grant or award · Stock Option (Right to Buy) +11,279 11,279
2024-08-12 Froimson Mark Director Purchase +1,400 $11.58 $16K 14,473
2024-06-12 Froimson Mark Director Grant or award +5,230 13,073
2024-06-12 Froimson Mark Director Grant or award · Stock Option (Right to Buy) +12,179 12,179
2023-06-14 Froimson Mark Director Grant or award +1,775 7,843

Page 1 of 2 · 25 trades